Cannabidiol converts NF-κB into a tumor suppressor in glioblastoma with defined antioxidative properties

Abstract

This evidence demonstrates how a clinically approved drug can convert NF-κB into a tumor suppressor and suggests a promising repurposing option for GBM therapy.